Cytotoxicity Studies of Novel Combretastatin and Pterostilbene Derivatives
Figure 2
(a) Dose response curves for stilbenes 1b–7b in breast cancer cells MDA-MB-23. Data are expressed as percentage growth of vehicle treated controls. Values represent the means ± SEM for three separate experiments carried out in triplicate; (b) the relationship: % cell growth of stilbene 1b (referenced scaffold) minus % cell growth of stilbene 2b–7b, respectively, and concentration.